HUNTINGTON BEACH, Calif. Life Science Intelligence (LSI) announced this month that another new group of 28 mostly privately-held medtech companies has recently been added to the EMT (Emerging Medical Technologies)® Database. According to LSI, this latest round of companies is collectively seeking over $162M ($32.5M Series A, $89.3M Series B, $20M Series C, $3M Series E, and $17.9M Series F). Many of the companies are also actively pursuing strategic partnerships and licensing deals with large medtech companies.

LSI’s EMT Database provides medical technology executives and venture capitalists with a searchable online resource allowing them to discover, partner, and capitalize on opportunities in emerging medtech start-up companies. Most of the companies in the database include Executive Summaries and Presentations.

Start-ups in the EMT Database represent many market segments, including: aesthetics, biomaterials, biotechnology, cardiovascular, cell therapy, dental, dermatology, diagnostics, drug delivery, endocrine, gastroenterology, gynecology, imaging, men’s health, neurology, oncology, ophthalmology, orthopedics, pain management, patient monitoring, respiratory, spine, surgery, urology, vascular, women’s health, and wound management.

Some of the firms and companies that have invested in or partnered with companies in the EMT Database include: Accuitive Ventures, Advanced Technology Ventures, Aesculap, Affinity Capital Partners, Alta Partners, Baird Venture Partners, Battelle Ventures, Bay City Capital, Boston Scientific (BSX), Canaan Ventures, Conmed (CNMD), Covidien (COV), CR Bard (BCR), Delphi Ventures, Domain Associates, Edwards Lifesciences (EW), Essex Woodlands, Frazier Healthcare Ventures, Galen Partners, Heidelberg Innovation, JJDC, Johnson & Johnson (JNJ), JP Morgan, Medtronic (MDT), Microsoft (MSFT), Morgenthaler Ventures, MPM Capital, NASA, Onset Ventures, Oxford BioScience Partners, Path4 Ventures, Prism Venture Partners, Rivervest Venture Partners, Sanderling Ventures, Sapient Capital, Schroder Ventures, Sofinnova Ventures, Split Rock Partners, St. Jude (STJ), Stryker (SYK), SV Life Sciences, Sycamore Ventures, Triathlon Medical Ventures, Versant Ventures, and Welch Allyn.

About Life Science Intelligence (LSI)®

LSI delivers high-quality market data and information to medical technology executives, entrepreneurs, and investors. LSI produces the EMT (Emerging Medical Technologies)® Database, medtech market reports, and provides global custom research services, including market assessments and physician surveys. In addition, LSI partners with top-tier information companies such as Health Research International (HRI) and Windhover/Medtech Insight to distribute their high-end information products.